Full-dose peginterferon Alfa-2a and low-dose ribavirin treatment of genotypes 1 and 4 chronic hepatitis C patients with end-stage renal disease

Clin Gastroenterol Hepatol. 2011 Nov;9(11):1004; author reply 1005. doi: 10.1016/j.cgh.2011.06.002. Epub 2011 Jun 13.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Female
  • Hepatitis C, Chronic / complications*
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Immunologic Factors / administration & dosage*
  • Interferon-alpha / administration & dosage*
  • Kidney Failure, Chronic / diagnosis*
  • Kidney Failure, Chronic / drug therapy*
  • Male
  • Polyethylene Glycols / administration & dosage*

Substances

  • Immunologic Factors
  • Interferon-alpha
  • Polyethylene Glycols